Goldman Sachs’s Alerian MLP Index ETNs due January 28 2044 AMJB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Sell
311,777
-30,392
-9% -$1.06M ﹤0.01% 3173
2026
Q1
$11.8M Buy
342,169
+14,231
+4% +$474K ﹤0.01% 2918
2025
Q4
$9.81M Sell
327,938
-11,281
-3% -$335K ﹤0.01% 3115
2025
Q3
$10M Sell
339,219
-90,644
-21% -$2.75M ﹤0.01% 2966
2025
Q2
$13M Buy
429,863
+5,313
+1% +$160K ﹤0.01% 2520
2025
Q1
$13.8M Buy
424,550
+2,836
+0.7% +$90.9K ﹤0.01% 2387
2024
Q4
$12.4M Buy
421,714
+46,775
+12% +$1.38M ﹤0.01% 2589
2024
Q3
$10.7M Sell
374,939
-3,110
-0.8% -$89.1K ﹤0.01% 2640
2024
Q2
$10.9M Buy
+378,049
New +$10.7M ﹤0.01% 2422

Other funds holding AMJB

Goldman Sachs's AMJB Position: Q2 2026 in Review

Goldman Sachs reduced its Alerian MLP Index ETNs due January 28 2044 (AMJB) stake by 8.9% in Q2 2026, selling an estimated $1.06M and leaving 311,777 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3173.

Goldman Sachs first reported a position in AMJB in Q2 2024 and has held it in 9 quarters since. The position peaked at $13.8M in Q1 2025. 73 funds tracked by Wall St. Rank hold AMJB as of Q2 2026.

  • Goldman Sachs held 311,777 shares of Alerian MLP Index ETNs due January 28 2044 worth $10.8M as of Q2 2026.
  • Goldman Sachs sold 30,392 Alerian MLP Index ETNs due January 28 2044 shares in Q2 2026, an estimated $1.06M.
  • Alerian MLP Index ETNs due January 28 2044 made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3173 holding.
  • Goldman Sachs first reported a position in Alerian MLP Index ETNs due January 28 2044 in Q2 2024 and has held it in 9 quarters since.
  • Goldman Sachs's Alerian MLP Index ETNs due January 28 2044 position peaked at $13.8M in Q1 2025.
  • 73 funds tracked by Wall St. Rank held Alerian MLP Index ETNs due January 28 2044 as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.